Direct-Acting Oral Anticoagulants: A Resident-Based Workshop to Improve Knowledge and Confidence
Introduction Direct-acting oral anticoagulant (DOAC) prescriptions have increased steadily since the first, dabigatran, was Food and Drug Administration-approved in 2010. They have multiple advantages over vitamin K antagonists including fixed dosing without coagulation lab monitoring, rapid onset a...
Enregistré dans:
Auteurs principaux: | , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Association of American Medical Colleges
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/511b1d672fe740d8ae9695db81278f28 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|